Dave Bautz

Dave Bautz is a seasoned professional in the biotechnology sector, currently serving as a Senior Biotech Analyst at Zacks Investment Research since February 2014, where responsibilities include leading analysis on small and mid-cap biotechnology companies, authoring detailed initiation reports, and evaluating clinical data across various therapeutic areas. Prior to this role, Bautz worked as an Associate Biotech Analyst, contributing to reports and valuation assessments for biotechnology firms. Bautz's earlier experience includes serving as an NRSA Postdoctoral Fellow at North Carolina State University and a Research Associate II at Human Genome Sciences. Bautz holds a PhD in Biochemistry from the University of North Carolina at Chapel Hill, alongside a Master's degree and a Bachelor's degree in Biochemistry from Virginia Tech.